High materiality7/10
Definium Therapeutics initiated with an Overweight at Wells Fargo
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Overweight target $68; price $43.17.
- Overweight target $68; price $43.17.
Key facts
- 01
Target: $68
- 02
Posted price: $43.17
- 03
Analyst firm: Wells Fargo
- 04
Analyst: Benjamin Burnett
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.